Dong Quai (Tcm) for Blood Circulation

Research suggests that Dong Quai (Angelica sinensis) is frequently incorporated into traditional Chinese medicine formulations specifically for its proposed blood-activating and circulation-promoting properties, appearing across studies examining conditions as varied as migraine, kidney disease, heart ischemia-reperfusion injury, and reproductive disorders. The available evidence consists predominantly of animal studies, data-mining analyses of TCM prescription patterns, and narrative reviews rather than rigorous clinical trials, with most studies examining Dong Quai as one component within multi-herb formulas rather than as an isolated agent, making it difficult to attribute specific circulatory effects to Dong Quai alone. One rat study raised a note of caution, finding that Dong Quai co-administered with antiplatelet medications altered drug metabolism and enzyme activity, suggesting potential herb-drug interactions that warrant attention. Overall, while the body of literature consistently positions Dong Quai as a blood-circulation herb within the TCM framework, the evidence remains largely preclinical and context-dependent, and stronger controlled human trials would be needed to draw firm conclusions about its standalone efficacy for improving circulation.